CGP-42112A is a potent angiotensin II receptor type 2 (AT2 receptor) agonist. It has a role as an angiotensin receptor agonist, a vasodilator agent, an antineoplastic agent, an anti-inflammatory agent and a neuroprotective agent.
CAT No: R1850
CAS No: 127060-75-7
Synonyms/Alias: 127060-75-7;Cgp 42112;Cgp-42112A;CGP-42112;CGP 42112A;Cgp 42112B;CGP42112A;CGP42112;MFCD00133611;9Q3V7W3XDD;CHEMBL1885579;L-Isoleucine, N-(1-(N-(N6-(N2-((phenylmethoxy)carbonyl)-L-arginyl)-N2-(N-(3-pyridinylcarbonyl)-L-tyrosyl)-L-lysyl)-L-histidyl)-L-prolyl)-;Nalpha-Nicotinoyl-Tyr-(Nalpha-Cbz-Arg)-Lys-His-Pro-Ile;(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid;Nicotinic acid-tyr-(N(sigma)-benzyloxycarbonyl-arg)lys-his-pro-ile-OH;N6-(((benzyloxy)carbonyl)-L-arginyl)-N2-(nicotinoyl-L-tyrosyl)-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-6-[[(2S)-5-(diaminomethylideneamino)-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-2-[[(2S)-3-(4-hydroxyphenyl)-2-(pyridine-3-carbonylamino)propanoyl]amino]hexanoyl]amino]-3-(3H-imidazol-4-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid;Nicotinic acid-tyrosyl-(N(sigma)-benzyloxycarbonyl-arginyl)lysyl-histidyl-prolyl-isoleucine-OH;[125I]CGP42112;[125I]-CGP42112;AngiotensinIIReceptorLigand;UNII-9Q3V7W3XDD;GTPL594;GTPL3944;SCHEMBL15524960;SCHEMBL16675400;DTXSID90155396;CHEBI:147302;EX-A7392;BDBM50514581;PDSP1_000402;PDSP2_000400;AKOS024457173;AKOS037648666;CGP-42112?;CS-3414;NCGC00167317-01;BS-15127;FA110425;HY-12405;CGP-42112A, >=95%, synthetic, solid;D83656;Q27075903;Angiotensin II Receptor Ligand Nicotinoyl-Tyr-Lys(Z-Arg)-His-Pro-Ile-OH;Angiotensin II Receptor Ligand (Nicotinoyl-Tyr-Lys(1)-His-Pro-Ile-OH.CbZ-Arg-(1));(2S,3S)-2-((S)-1-((5S,12S,15S)-15-((1H-Imidazol-5-yl)methyl)-5-(3-guanidinopropyl)-12-((S)-3-(4-hydroxyphenyl)-2-(nicotinamido)propanamido)-3,6,13-trioxo-1-phenyl-2-oxa-4,7,14-triazahexadecan-16-oyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid;(2S,3S)-2-{[(2S)-1-[(2S)-2-[(2S)-6-[(2S)-2-{[(BENZYLOXY)CARBONYL]AMINO}-5-CARBAMIMIDAMIDOPENTANAMIDO]-2-[(2S)-3-(4-HYDROXYPHENYL)-2-(PYRIDIN-3-YLFORMAMIDO)PROPANAMIDO]HEXANAMIDO]-3-(1H-IMIDAZOL-4-YL)PROPANOYL]PYRROLIDIN-2-YL]FORMAMIDO}-3-METHYLPENTANOIC ACID;L-ISOLEUCINE, N-(3-PYRIDINYLCARBONYL)-L-TYROSYL-N6-(N2-((PHENYLMETHOXY)CARBONYL)-L-ARGINYL)-L-LYSYL-L-HISTIDYL-L-PROLYL-;N(6)-[[(phenylmethoxy)carbonyl]-L-Arg-]-N(2)-[[(pyridin-3-yl)carbonyl]-L-Tyr-]-L-Lys-L-His-L-Pro-L-Ile-OH;N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridin-3-ylcarbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;N(6)-{N(2)-[(benzyloxy)carbonyl]-L-arginyl}-N(2)-[N-(pyridine-3-carbonyl)-L-tyrosyl]-L-lysyl-L-histidyl-L-prolyl-L-isoleucine;N-(3-PYRIDINYLCARBONYL)-L-TYROSYL-N6-(N2-((PHENYLMETHOXY)CARBONYL)-L-ARGINYL)-L-LYSYL-L-HISTIDYL-L-PROLYL-L-ISOLEUCINE;
Chemical Name: N6-(((benzyloxy)carbonyl)-L-arginyl)-N2-(nicotinoyl-L-tyrosyl)-L-lysyl-L-histidyl-L-prolyl-L-isoleucine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C52H69N13O11 |
M.W/Mr. | 1052.2 |
Sequence | Three Letter Code:nicotinoyl-Tyr-Lys(1)-His-Pro-Ile-OH.Cbz-Arg-(1) |
Appearance | White solid |
Purity | ≥95% |
Activity | Potent AT2 angiotensin II receptor agonist. |
Source# | Synthetic |
Long-term Storage Conditions | Soluble to 1 mg/ml in water |
Shipping Condition | Evaluation sample solution : ship with blue ice; All other available size: ship with RT , or blue ice upon request |
InChI | InChI=1S/C52H69N13O11/c1-3-32(2)43(50(73)74)64-48(71)42-17-11-25-65(42)49(72)41(27-36-29-56-31-59-36)62-46(69)39(60-47(70)40(26-33-18-20-37(66)21-19-33)61-44(67)35-14-9-22-55-28-35)15-7-8-23-57-45(68)38(16-10-24-58-51(53)54)63-52(75)76-30-34-12-5-4-6-13-34/h4-6,9,12-14,18-22,28-29,31-32,38-43,66H,3,7-8,10-11,15-17,23-27,30H2,1-2H3,(H,56,59)(H,57,68)(H,60,70)(H,61,67)(H,62,69)(H,63,75)(H,64,71)(H,73,74)(H4,53,54,58)/t32-,38-,39-,40-,41-,42-,43-/m0/s1 |
InChI Key | UXGNARZDONUMMK-LRMQDCNJSA-N |
Canonical SMILES | CCC(C)C(C(=O)O)NC(=O)C1CCCN1C(=O)C(CC2=CN=CN2)NC(=O)C(CCCCNC(=O)C(CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C5=CN=CC=C5 |
Isomeric SMILES | CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCCCNC(=O)[C@H](CCCN=C(N)N)NC(=O)OCC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)C5=CN=CC=C5 |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com